在HSCT/BMT之后,KIR/HLA I类共表达和移植结果来自HLA匹配的兄弟捐赠者
Joanna Dębska-Zielkowska1, Bartosz Słomiński1, Hanna Zielińska1
1Department of Medical Immunology, Medical University of Gdańsk, Gdańsk, Poland.
Transplant immunology
|August 6, 2025
概括
杀手免疫球蛋白类受体 (KIR) 和人类白细胞抗原 (HLA) 的相互作用影响了造血干细胞移植 (HSCT) 的结果. 在相关捐赠者选择之前的KIR/HLA分析可能会减少移植并发症,如移植对宿主疾病 (GvHD).
科学领域:
- 免疫遗传学 免疫遗传学
- 移植免疫学 移植免疫学
背景情况:
- 自然杀手 (NK) 细胞利用杀手免疫球蛋白类受体 (KIR) 调节免疫反应.
- 人类白细胞抗原 (HLA) I类分子通过结合KIRs来抑制NK细胞活性.
- 在造血干细胞移植 (HSCT) 和骨髓移植 (BMT) 中,NK细胞活性调节至关重要,因为正常的NK功能会影响移植结果.
研究的目的:
- 在HSCT的背景下,研究NK细胞上的KIR和I类HLA之间的相互作用.
- 确定缺失的KIR配体 (MSL) 和KIR单元类型对HSCT结果的影响,包括移植对宿主疾病 (GvHD),复发,死亡率,感染和细胞恢复.
主要方法:
- 对59名接受兄弟捐赠者移植的HSCT患者 (AML,CML,MDS,ALL) 的分析.
- 检查与移植结果相关的KIR单元类型 (AA与Bx) 和KIR缺失连接体 (MSL) 状态.
- 统计分析以关联KIR/HLA因子与GvHD发病率,中性粒细胞移植和其他并发症.
主要成果:
- 在捐赠者中,哈普洛型AA在骨髓质疏松症候群 (MDS) 患者中更为频繁,并与慢性GvHD (cGvHD) 的增加有关.
- 在MDS患者中,在28天内观察到AA供体单双型和中性粒细胞数恢复之间存在显著联系.
- 在急性髓性白血病 (AML) 患者中,KIR MSL值和cGvHD之间发现了强烈的相关性.
结论:
- 基尔/HLA I 类分析是血液移植中相关的供体选择的宝贵工具.
- 实施KIR/HLA类型可能会改善HSCT结果并减轻诸如GvHD.等并发症.
相关概念视频
01:24Tissue Transplantation
520
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
520
01:22Bone Marrow Sampling and Transplants
500
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
500
01:40Cell-mediated Immune Responses
72.7K
Overview
72.7K
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:19Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K